Volume 26 - Issue 12 - December 2018

pills in hand
​​​​​​Findings from a recent population-based study suggest an association between dipeptidyl peptidase 4 inhibitor use and risk of developing bullous pemphigoid.
Melissa Weiss, Associate Editor
Melissa Weiss, Associate Editor
Melissa Weiss, Associate Editor
Adam J. Carter, MD; Alexander Dane, DO; Kristyna Lee, MD, MPH; and Arlene Rogachefsky, MD
Cynthia M. Magro, MD; Maira Foseca, MD; and Amin A. Hedayat, MD
Dr. Linos
Section Editor, Benjamin Barankin, MD, FRCPC
neck lesion
Santana D. VanDyke, BS, and Barrett J. Zlotoff, MD
Olivia Bosshardt Hughes, MD; Ariana Eginli, MD; and Rechelle Tull, MD